Pfizer Aktie News

Drug developer Arvinas said on Wednesday it will grant commercialization rights of an experimental breast cancer treatment it was developing with Pfizer to a third party.

High-yield dividend stocks entice investors with payouts two to four times higher than the S&P 500's 1.4% average yield. But high yield often signals trouble -- sluggish growth, stretched payout ratios, or sector headwinds.

The S&P 500 is offering a skinny yield of 1.2%. The average healthcare stock has a yield of 1.7%.

Need investment income? Dividend stocks are an obvious option to consider.

If you're a long-term investor, why should you be paying closer attention to pharmaceutical giant Pfizer (PFE -3.98%)? Because of its dividend, of course!

Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively.

Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Analyst forecasts suggest top ten S&P 500 dividend 'dogs' could deliver 20.45% to 38.5% net gains by September 2026, with an average gain of 27.35%. Stocks like Amcor, Healthpeak, Conagra, Pfizer, and Verizon offer the best combination of h...

Shares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.